- Home
- NKTR vs OM Comparison
NKTR vs OM Comparison
Compare NKTR & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- OM
- Stock Information
- Founded
- NKTR 1990
- OM 2003
- Country
- NKTR United States
- OM United States
- Employees
- NKTR N/A
- OM N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NKTR Health Care
- OM Health Care
- Exchange
- NKTR Nasdaq
- OM Nasdaq
- Market Cap
- NKTR 200.6M
- OM 37.3M
- IPO Year
- NKTR 1994
- OM 2020
- Fundamental
- Price
- NKTR $1.12
- OM $0.49
- Analyst Decision
- NKTR Hold
- OM Buy
- Analyst Count
- NKTR 3
- OM 6
- Target Price
- NKTR $1.00
- OM $4.42
- AVG Volume (30 Days)
- NKTR 882.7K
- OM 3.0M
- Earning Date
- NKTR 11-05-2024
- OM 11-05-2024
- Dividend Yield
- NKTR N/A
- OM N/A
- EPS Growth
- NKTR N/A
- OM N/A
- EPS
- NKTR N/A
- OM N/A
- Revenue
- NKTR $93,157,000.00
- OM $116,425,000.00
- Revenue This Year
- NKTR N/A
- OM N/A
- Revenue Next Year
- NKTR N/A
- OM $14.26
- P/E Ratio
- NKTR N/A
- OM N/A
- Revenue Growth
- NKTR 6.17
- OM N/A
- 52 Week Low
- NKTR $0.41
- OM $0.47
- 52 Week High
- NKTR $1.93
- OM $13.93
- Technical
- Relative Strength Index (RSI)
- NKTR 38.78
- OM 16.12
- Support Level
- NKTR $1.19
- OM $0.50
- Resistance Level
- NKTR $1.35
- OM $0.56
- Average True Range (ATR)
- NKTR 0.10
- OM 0.06
- MACD
- NKTR -0.01
- OM 0.09
- Stochastic Oscillator
- NKTR 13.33
- OM 6.61
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.